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Using reporting guidelines to publish paediatric research  
Katie Harron, London School of Hygiene and Tropical Medicine 
Many medicines and devices used for the healthcare of children are unlicensed and untested for use 
in paediatrics, and clinicians often have to rely on evidence in adults that may not be generalisable 
to children.
1, 2
 There are a number of reasons why evidence in adults cannot always be safely 
extrapolated to children, including different pharmacokinetic and pharmacodynamics processes, and 
drug safety and efficacy being dependent on stage of development. Growing recognition of these 
issues has led to initiatives to increase the number of paediatric trials.
3
 In addition, recognition of 
the important differences in design and interpretation of trials conducted in adults and children - 
including ethical issues, validity of outcomes, age- and developmental stage-specific harms and 
confounders – has highlighted deficiencies in the quality of paediatric trial conduct and reporting, 
and prompted repeated calls for child-specific reporting guidelines.
4
  
Reporting guidelines such as CONSORT (Consolidated Standards Of Reporting Trials) and STROBE 
(STrengthening the Reporting of OBservational studies in Epidemiology) aim to improve 
transparency, allowing identification of potential biases, critical assessments of robustness, and 
replication in different settings.
5, 6
 Many leading journals actively endorse reporting guidelines and 
refer authors to the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) 
network website (www.equator-network.org). The EQUATOR network was established to improve 
the reliability and usability of health research literature by facilitating accurate and complete 
reporting of research studies.
7
  
Despite the comprehensive collection of existing resources and reporting guidelines available on the 
EQUATOR website, there has to date been a lack of guidance for the reporting of paediatric studies.
8
 
Aiming to fill this gap, and in response to the need to improve quality in reporting of paediatric 
research, several child-specific extensions to established guidelines are under development, 
including for CONSORT, SPIRIT (Standard Protocol Items for Randomised Trials), and PRISMA 
(Preferred Reporting Items for Systematic reviews and Meta-analysis).
5, 8-10
 These initiatives will 
complement previous guidelines by recommending consideration of paediatric-specific issues, 
including choice of appropriate outcomes, stratification by age or development, dosing or 
formulation, safety, and ethical considerations. For example, detailed reporting of the age 
distribution of study participants is vital for understanding outcomes, treatment effects and 
potential effects of growth and maturation; reporting the validity of outcome measures in paediatric 
populations is also important, as valid outcomes for adult populations may not be relevant across 
childhood.
11
 Reporting long-term safety outcomes is also required in situations where harms may 
appear later on in development.  
The most informative reporting guidelines are underpinned by robust methodological development, 
typically through establishing consensus from experts and stakeholders in an iterative process of 
feedback and review. However, providing robust evidence about the impact of guidelines on quality 
of reporting is challenging.
12, 13
 The list of 320 reporting guidelines currently published on the 
EQUATOR website is continuing to grow (as of July 2016), and whilst some argue that these 
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checklists represent another hurdle to publication, others recognise that any tool to improve the 
quality and transparency of research reports can only increase the likelihood of manuscript 
acceptance.
14
 In addition to supporting authors in producing accurate and transparent 
representations of their research, reporting checklists are also a valuable aid for peer reviewers 
assessing the quality of studies submitted for publication.
15
 Despite the well-recognised 
shortcomings of peer-review, including inevitable inconsistencies, limited capacity to identify all 
errors or weaknesses, and potential reviewer biases, the current system is a crucial component of 
scientific research publication. Encouraging the use of reporting checklists can help to improve the 
process and support reviewers in providing quality reviews.
16
 
Journals implement reporting guidelines in various ways, but commonly refer to relevant reporting 
guidelines in their Instructions to Authors. Some journals have explicit philosophies of transparency, 
accuracy and compl teness in reporting. For example, the BMJ journal group’s “Transparency Policy” 
requests that authors follow complete reporting checklists prior to submission 
(www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/transparency-policy). 
For Archives of Disease in Childhood, as for other BMJ journals, authors are referred to the EQUATOR 
Network website and encouraged to use appropriate guidelines, to “ensure that you provide enough 
information for editors, peer reviewers and readers to understand how the research was performed 
and to judge whether the findings are likely to be reliable.” Other journals, such as PLoS Medicine, 
require authors to submit appropriate checklists alongside their manuscript, or to provide an 
explanation if no relevant guideline exists.  
Given the challenges in conducting randomised trials in children, observational studies based on 
population-based administrative data sources are increasingly being used to provide evidence and 
support quality improvement for paediatrics. Administrative or electronic health data sources 
contain individual-level records primarily collected for reasons other than research (e.g. financial or 
clinical management), and can provide rich, detailed information on patient pathways.
17
 However, 
there are unique challenges for the analysis of such data.
18
 Administrative data do not always 
contain the complete, accurate information that researchers require. For example, a study of 
children with and without a diabetes requires accurate classification of the disease, which is reliant 
on i) the clinician recognising the diagnosis, ii) the diagnosis being recorded in clinical notes, iii) 
medical coders correctly coding the diagnosis and iv) researchers including the correct codes in their 
analysis. Omissions in any of these steps could lead to missing information, which could in turn lead 
to bias. Transparency of reporting is therefore key to producing valid and reliable research based on 
administrative data. The REporting of studies Conducted using Observational Routinely-collected 
health Data (RECORD) initiative aims to complement the STROBE guidelines by providing guidance 
on issues relating specifically to administrative data, including the use of data linkage, access and 
availability of data, and code list validation.
19
 For example, RECORD recommends that algorithms or 
codes used to identify the study population, exposures, outcomes and other variables are listed in 
detail; that any filtering based on data quality, data availability or linkage should be described; and 
that the implications of using data not collected specifically for research should be discussed.
19
  
Positive public perception of paediatric research is crucial, both in facilitating recruitment of children 
into trials, and in exploiting existing data sources for child health research. Both authors and journals 
have an important role to play in supporting the public in making informed decisions about the use 
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3 
of their data, through maintaining a high level of transparency and quality in reporting of paediatric 
health research. The use of reporting guidelines by authors and reviewers can aid careful 
interpretation of findings and enable those working in health policy to make evidence-based 
decisions on paediatric care and health systems.  
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